Azacitidine with or without Entinostat for the treatment of therapy-related myeloid neoplasm: further results of the E1905 North American Leukemia Intergroup study

Therapy-related myeloid neoplasms (tMN) are serious late effects of the treatment of cancer with poor response to conventional treatment. Azacitidine (AZA) has been used to treat patients with tMN but current data are retrospective. We present here 47 tMN patients prospectively enrolled as a specifi...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Br J Haematol
Glavni autori: Prebet, Thomas, Sun, Zhuoxin, Ketterling, Rhett P., Zeidan, Amer, Greenberg, Peter, Herman, James, Juckett, Mark, Smith, Mitchell R., Malick, Lisa, Paietta, Elisabeth, Czader, Magdalena, Figueroa, Maria, Gabrilove, Janice, Erba, Harry P., Tallman, Martin S., Litzow, Mark, Gore, Steven D.
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4794257/
https://ncbi.nlm.nih.gov/pubmed/26577691
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.13832
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items